desoxycorticosterone has been researched along with Absence Status in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bidlingmaier, F; Dörr, HG; Holthausen, H; Knorr, D; Kuhnle, U | 1 |
| Cohen, AL; Karp, E; Kokate, TG; Rogawski, MA | 1 |
2 other study(ies) available for desoxycorticosterone and Absence Status
| Article | Year |
|---|---|
Etomidate: a selective adrenocortical 11 beta-hydroxylase inhibitor.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Child; Corticosterone; Cortisone; Cortodoxone; Desoxycorticosterone; Etomidate; Humans; Hydrocortisone; Hydroxyprogesterones; Imidazoles; Male; Progesterone; Status Epilepticus; Steroid 11-beta-Hydroxylase; Steroid Hydroxylases | 1984 |
Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice.
Topics: Animals; Anticonvulsants; Clonazepam; Desoxycorticosterone; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Isomerism; Kainic Acid; Male; Mice; Muscarinic Agonists; N-Methylaspartate; Pilocarpine; Progesterone; Seizures; Status Epilepticus; Steroids | 1996 |